Literature DB >> 8648729

Gene transfer into mammalian cells by a Rous sarcoma virus-based retroviral vector with the host range of the amphotropic murine leukemia virus.

E V Barsov1, S H Hughes.   

Abstract

We have constructed and characterized a Rous sarcoma virus-based retroviral vector with the host range of the amphotropic murine leukemia virus (MLV). The chimeric retroviral genome was created by replacing the env coding region in the replication-competent retroviral vector RCASBP(A) with the env region from an amphotropic MLV. The recombinant vector RCASBP-M(4070A) forms particles containing MLV Env glycoproteins. The vector replicates efficiently in chicken embryo fibroblasts and is able to transfer genes into mammalian cells. Vector stocks with titers exceeding 10(6) CFU/ml on mammalian cells can be easily prepared by passaging transfected chicken embryo fibroblasts. Since the vector is inherently defective in mammalian cells, it appears to have the safety features required for gene therapy.

Entities:  

Mesh:

Year:  1996        PMID: 8648729      PMCID: PMC190270     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Efficient incorporation of human CD4 protein into avian leukosis virus particles.

Authors:  J A Young; P Bates; K Willert; H E Varmus
Journal:  Science       Date:  1990-12-07       Impact factor: 47.728

2.  Comparison of Rous sarcoma virus RNA processing in chicken and mouse fibroblasts: evidence for double-spliced RNA in nonpermissive mouse cells.

Authors:  S L Berberich; M Macias; L Zhang; L P Turek; C M Stoltzfus
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

3.  Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction.

Authors:  R M Horton; Z L Cai; S N Ho; L R Pease
Journal:  Biotechniques       Date:  1990-05       Impact factor: 1.993

4.  Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity.

Authors:  K A Page; N R Landau; D R Littman
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

Review 5.  Vectors and genes for improvement of animal strains.

Authors:  S H Hughes; C J Petropoulos; M J Federspiel; P Sutrave; S Forry-Schaudies; J A Bradac
Journal:  J Reprod Fertil Suppl       Date:  1990

6.  Human immunodeficiency virus pseudotypes with expanded cellular and species tropism.

Authors:  D H Spector; E Wade; D A Wright; V Koval; C Clark; D Jaquish; S A Spector
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

7.  Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range.

Authors:  N R Landau; K A Page; D R Littman
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

8.  Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus.

Authors:  A D Miller; J V Garcia; N von Suhr; C M Lynch; C Wilson; M V Eiden
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

9.  Avian sarcoma virus gag precursor polypeptide is not processed in mammalian cells.

Authors:  V M Vogt; D A Bruckenstein; A P Bell
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

10.  A variant Schmidt-Ruppin strain of Rous sarcoma virus with increased affinity for mammalian cells.

Authors:  S Kawai; M Nishizawa; H Shinno-Kohno; K Shiroki
Journal:  Jpn J Cancer Res       Date:  1989-12
View more
  20 in total

1.  Genomic stability of murine leukemia viruses containing insertions at the Env-3' untranslated region boundary.

Authors:  C R Logg; A Logg; C K Tai; P M Cannon; N Kasahara
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Delivery of short hairpin RNA sequences by using a replication-competent avian retroviral vector.

Authors:  Jennifer L Bromberg-White; Craig P Webb; Veronique S Patacsil; Cindy K Miranti; Bart O Williams; Sheri L Holmen
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

3.  High-frequency epigenetic repression and silencing of retroviruses can be antagonized by histone deacetylase inhibitors and transcriptional activators, but uniform reactivation in cell clones is restricted by additional mechanisms.

Authors:  Richard A Katz; Emily Jack-Scott; Anna Narezkina; Ivan Palagin; Pamela Boimel; Joseph Kulkosky; Emmanuelle Nicolas; James G Greger; Anna Marie Skalka
Journal:  J Virol       Date:  2007-01-03       Impact factor: 5.103

4.  Identification of cellular proteins that maintain retroviral epigenetic silencing: evidence for an antiviral response.

Authors:  Andrey Poleshko; Ivan Palagin; Rugang Zhang; Pamela Boimel; Carolyn Castagna; Peter D Adams; Anna Marie Skalka; Richard A Katz
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

5.  Modification of integration site preferences of an HIV-1-based vector by expression of a novel synthetic protein.

Authors:  Robert M Silvers; Johanna A Smith; Michael Schowalter; Samuel Litwin; Zhihui Liang; Kyla Geary; René Daniel
Journal:  Hum Gene Ther       Date:  2010-03       Impact factor: 5.695

6.  Wortmannin potentiates integrase-mediated killing of lymphocytes and reduces the efficiency of stable transduction by retroviruses.

Authors:  R Daniel; R A Katz; G Merkel; J C Hittle; T J Yen; A M Skalka
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

7.  Retroviral replicating vectors in cancer.

Authors:  Christopher R Logg; Joan M Robbins; Douglas J Jolly; Harry E Gruber; Noriyuki Kasahara
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

8.  Retroviral DNA methylation and epigenetic repression are mediated by the antiviral host protein Daxx.

Authors:  Natalia Shalginskikh; Andrey Poleshko; Anna Marie Skalka; Richard A Katz
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

9.  Transduction of terminally differentiated neurons by avian sarcoma virus.

Authors:  James G Greger; Richard A Katz; Konstantin Taganov; Glenn F Rall; Anna Marie Skalka
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  Alpharetroviral vector-mediated gene therapy for X-CGD: functional correction and lack of aberrant splicing.

Authors:  Kerstin B Kaufmann; Christian Brendel; Julia D Suerth; Uta Mueller-Kuller; Linping Chen-Wichmann; Joachim Schwäble; Shweta Pahujani; Hana Kunkel; Axel Schambach; Christopher Baum; Manuel Grez
Journal:  Mol Ther       Date:  2012-12-04       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.